SCM
GILD icon

Sio Capital Management’s Gilead Sciences GILD Stock Holding History

Sio Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-65,500
Closed -$4.58M – 72
2021
Q3 		$4.58M Buy
+65,500
New +$4.6M 1.46% 21
2020
Q1 		– Sell
-186,000
Closed -$12.1M – 75
2019
Q4 		$12.1M Buy
+186,000
New +$12.1M 2.88% 11
2019
Q2 		– Sell
-245,968
Closed -$16M – 74
2019
Q1 		$16M Buy
245,968
+149,488
+155% +$9.94M 4.32% 3
2018
Q4 		$6.04M Buy
+96,480
New +$6.74M 2.2% 14

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sio Capital Management's GILD Position: Q4 2021 in Review

Sio Capital Management sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 65,500 shares — an estimated $4.58M sold.

Sio Capital Management first reported a position in GILD in Q4 2018 and held it in 4 quarters. The position peaked at $16M in Q1 2019. 1,681 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

  • Sio Capital Management reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
  • Sio Capital Management sold 65,500 Gilead Sciences shares in Q4 2021, an estimated $4.58M.
  • Sio Capital Management first reported a position in Gilead Sciences in Q4 2018 and held it in 4 quarters.
  • Sio Capital Management's Gilead Sciences position peaked at $16M in Q1 2019.
  • 1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Sio Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.